Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × AIDS-related Kaposi sarcoma × halofuginone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 AIDS-related Kaposi sarcoma 1

Interventions

Paclitaxel 2 nirogacestat 1 halofuginone 1 etoposide phosphate 1 Thalidomide 1 Sunitinib 1 Semaxinib 1 Saquinavir 1 Ritonavir 1 Peripheral Blood Stem Cell Transplantation 1 Nelfinavir 1 Interleukin-12 Subunit p35 1 Indinavir 1 Ifosfamide 1 Filgrastim 1 Etoposide 1 Cidofovir 1 Carboplatin 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00064142 2013-06-05

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡